| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Amplification of anti-melanoma activity of mistletoe extracts by enrichment with solubilized triterpene acids
|
Strüh, C.M.
|
|
2011
|
18 |
S1 |
p. S8-
1 p.
|
artikel
|
| 2 |
An online documentation for specific courses of therapy in oncology: Www.bestcase-oncology.com
|
Müller-Hübenthal, Boris
|
|
2011
|
18 |
S1 |
p. S16-S17
2 p.
|
artikel
|
| 3 |
Aqueous mistletoe extracts versus purified mistletoe lectin-I (pML-I): Effects on melanoma growth and spread in a human melanoma xenograft scid mouse model
|
Dahl, A.
|
|
2011
|
18 |
S1 |
p. S18-
1 p.
|
artikel
|
| 4 |
A randomized placebo controlled study on Viscum album (Iscador P) treatment of Equine Sarcoids in horses
|
Christen-Clottu, O.
|
|
2011
|
18 |
S1 |
p. S13-S14
2 p.
|
artikel
|
| 5 |
Assessment of extracts from mistletoe (Viscum album) for herb–drug interaction by inhibition and induction of cytochrome P450 activities
|
Doehmer, J.
|
|
2011
|
18 |
S1 |
p. S19-
1 p.
|
artikel
|
| 6 |
Author Index
|
|
|
2011
|
18 |
S1 |
p. S27-S28
2 p.
|
artikel
|
| 7 |
Clinical outcome study in pancreatic carcinoma using Viscum album therapy in an integrative approach
|
Spahn, G.
|
|
2011
|
18 |
S1 |
p. S13-
1 p.
|
artikel
|
| 8 |
Clinical research on mistletoe therapy in cancer – Status quo, current projects and developments
|
Kienle, Gunver S.
|
|
2011
|
18 |
S1 |
p. S5-
1 p.
|
artikel
|
| 9 |
Comparative investigation of monosaccharides and sugar alcohols in mistletoes (Viscum album L.) from different host trees
|
Kohl, Mira
|
|
2011
|
18 |
S1 |
p. S20-S21
2 p.
|
artikel
|
| 10 |
Cyclodextrin solubilised triterpene extracts show anti-tumorigenic effects on B16.F10 melanoma cells in vitro
|
Jäger, S.
|
|
2011
|
18 |
S1 |
p. S20-
1 p.
|
artikel
|
| 11 |
Different routes of application in mistletoe therapy – Effect on bone marrow and blood profile. Clinical significance
|
Kuehn, Jürgen Johannes
|
|
2011
|
18 |
S1 |
p. S11-
1 p.
|
artikel
|
| 12 |
Diurnal cortisol profile in breast cancer patients before and during treatment with Viscum album (Iscador® P) for 3 or 6 months
|
Staudt, A.
|
|
2011
|
18 |
S1 |
p. S25-S26
2 p.
|
artikel
|
| 13 |
Does a treatment with Viscum album (Iscador® P) in patients with breast cancer influence the expression of the T-cell receptor (TCR)-zeta chains of T- and NK-cells?
|
Hagens, C.v.
|
|
2011
|
18 |
S1 |
p. S24-
1 p.
|
artikel
|
| 14 |
Dose-escalation-study with a mistletoe extract from the ash tree as intravesical instillation in patients with superficial bladder cancer: An ICH/GCP phase Ib/IIa study
|
Eisenbraun, Jürgen
|
|
2011
|
18 |
S1 |
p. S15-
1 p.
|
artikel
|
| 15 |
Editorial
|
Scheer, Rainer
|
|
2011
|
18 |
S1 |
p. S1-
1 p.
|
artikel
|
| 16 |
Editorial
|
Scheer, Rainer
|
|
2011
|
18 |
S1 |
p. S2-
1 p.
|
artikel
|
| 17 |
Editorial Board
|
|
|
2011
|
18 |
S1 |
p. CO2-
1 p.
|
artikel
|
| 18 |
Effect of Viscum album lipohilic extract on human immunocompetent cells in vitro
|
Weissenstein, U.
|
|
2011
|
18 |
S1 |
p. S22-S23
2 p.
|
artikel
|
| 19 |
Effects of Viscum album L. extracts in neuroblastoma in vitro and in vivo
|
Delebinski, Catharina I.
|
|
2011
|
18 |
S1 |
p. S19-
1 p.
|
artikel
|
| 20 |
Genuine bilayer formation during glancing impact of drops on liquid surfaces both covered by lipid monolayers
|
Vranceanu, M.
|
|
2011
|
18 |
S1 |
p. S7-S8
2 p.
|
artikel
|
| 21 |
High dose intravenous mistletoe treatment – Clinical results, laboratory findings and adverse events in a series of 17 patients with 107 intravenous applications
|
Wiebelitz, K.R.
|
|
2011
|
18 |
S1 |
p. S11-
1 p.
|
artikel
|
| 22 |
Interactions between proteins of mistletoe or human serum and lipid membranes
|
Klapper, Y.
|
|
2011
|
18 |
S1 |
p. S20-
1 p.
|
artikel
|
| 23 |
Lectins are the pharmacologically active constituents in the standardized mistletoe extract PS76A2 (Lektinol®)
|
Mengs, U.
|
|
2011
|
18 |
S1 |
p. S21-
1 p.
|
artikel
|
| 24 |
Lectins – Potential sources and potential benefits
|
Kreis, Wolfgang
|
|
2011
|
18 |
S1 |
p. S3-
1 p.
|
artikel
|
| 25 |
Localization of mistletoe lectins ML I-III in Viscum album L. by immunofluorescent and immunogold labeling
|
Blaschek, W.
|
|
2011
|
18 |
S1 |
p. S7-
1 p.
|
artikel
|
| 26 |
Mistletoe and chemotherapy responsiveness of different scales in oncological patients undergoing chemotherapy
|
Kröz, M.
|
|
2011
|
18 |
S1 |
p. S16-
1 p.
|
artikel
|
| 27 |
Mistletoe lectins as biologically active substances in aqueous mistletoe extracts
|
Pfüller, U.
|
|
2011
|
18 |
S1 |
p. S3-S4
2 p.
|
artikel
|
| 28 |
Mistletoe therapy for advanced pancreatic cancer. A group-sequential, randomised, open label study phase III ISRCTN 70760582
|
Tröger, Wilfried
|
|
2011
|
18 |
S1 |
p. S26-
1 p.
|
artikel
|
| 29 |
Mistletoe therapy in adjuvant and palliative therapy of pancreatic carcinoma: Concepts–facts–perspectives
|
Matthes, H.
|
|
2011
|
18 |
S1 |
p. S6-
1 p.
|
artikel
|
| 30 |
Mistletoe therapy in anthroposophical hospitals in Switzerland
|
Ziegler, R.
|
|
2011
|
18 |
S1 |
p. S17-
1 p.
|
artikel
|
| 31 |
Molecular approaches for individualized tumor therapy with standard drugs, phytochemicals, and medicinal herbs
|
Efferth, Thomas
|
|
2011
|
18 |
S1 |
p. S4-
1 p.
|
artikel
|
| 32 |
Multimodal Viscum album L. treatment in an integrative oncological setting in patients with advanced pancreatic carcinoma
|
Schad, F.
|
|
2011
|
18 |
S1 |
p. S13-
1 p.
|
artikel
|
| 33 |
NCCAM/NCI phase 1 study of mistletoe extract and Gemcitabine in patients with advanced solid tumors
|
Mansky, P.J.
|
|
2011
|
18 |
S1 |
p. S12-
1 p.
|
artikel
|
| 34 |
Observational study on treatment of lymphocytic Non Hodgkin's Lymphoma (CLL) with Viscum album products Helixor P or A: Clinical course and safety
|
Gutsch, J.
|
|
2011
|
18 |
S1 |
p. S10-
1 p.
|
artikel
|
| 35 |
Options and limitations of ductal pancreatic cancer treatment
|
Seufferlein, Thomas
|
|
2011
|
18 |
S1 |
p. S5-S6
2 p.
|
artikel
|
| 36 |
Orally administered Viscum album Quercus dilutions in the therapy of feline fibrosarcoma in cats
|
Biegel, U.
|
|
2011
|
18 |
S1 |
p. S24-
1 p.
|
artikel
|
| 37 |
Organ specific and seasonal accumulation of viscotoxin-isoforms in Viscum album ssp. album
|
Urech, K.
|
|
2011
|
18 |
S1 |
p. S7-
1 p.
|
artikel
|
| 38 |
Quality of life during mistletoe therapy of cancer patients – An exploratory study with the additional use of questionnaires
|
Brandenberger, M.
|
|
2011
|
18 |
S1 |
p. S15-
1 p.
|
artikel
|
| 39 |
Randomised, open phase II study of tolerance, safety and efficacy of Viscum album extract in the palliative, additive treatment of advanced non-small cell lung carcinoma (NSCLC)
|
Grah, Christian
|
|
2011
|
18 |
S1 |
p. S14-S15
2 p.
|
artikel
|
| 40 |
Retrolective studies on the survival of cancer patients treated with mistletoe extracts – A meta analysis
|
Ostermann, T.
|
|
2011
|
18 |
S1 |
p. S16-
1 p.
|
artikel
|
| 41 |
Revision of the summary of product characteristic of anthroposophic preparations in parenteral dosage forms containing mistletoe – Result of a compromise between the marketing authorization holders and the German Federal Institute for Drugs and Medical Devices
|
Werner, C.
|
|
2011
|
18 |
S1 |
p. S5-
1 p.
|
artikel
|
| 42 |
Safety of higher dosages of Viscum album L. in animals and humans – Systematic review of immune changes and safety parameters
|
Kienle, Gunver S.
|
|
2011
|
18 |
S1 |
p. S11-S12
2 p.
|
artikel
|
| 43 |
Selective inactivation of the B-subunit of mistletoe lectins and other RIP-II-lectins in ionic liquids
|
Pfüller, U.
|
|
2011
|
18 |
S1 |
p. S21-
1 p.
|
artikel
|
| 44 |
Selective quantification of mistletoe lectin I in pressed mistletoe juice after inhibition of mistletoe lectin II and III
|
Eisenbeiß, W.F.
|
|
2011
|
18 |
S1 |
p. S19-S20
2 p.
|
artikel
|
| 45 |
Sensitivity of primary cultures of breast cancer cells to different Iscador®-preparations
|
Simões-Wüst, A.P.
|
|
2011
|
18 |
S1 |
p. S22-
1 p.
|
artikel
|
| 46 |
State of the art and new developments of anthroposophic mistletoe therapy – Results from a series of expert conferences hosted by the German anthroposophic doctor's association (GAAeD) 2008–2011
|
Breitkreuz, Thomas
|
|
2011
|
18 |
S1 |
p. S5-
1 p.
|
artikel
|
| 47 |
State version of autonomic regulation (aR): A new scale to distinguish between autonomic constitution and loss of regulation with regards to chemo- and mistletoe sensitivity
|
Kröz, M.
|
|
2011
|
18 |
S1 |
p. S25-
1 p.
|
artikel
|
| 48 |
Supportive therapy with mistletoe extract in tumor patients – Results of four controlled pharmacoepidemiological cohort studies as basis for prospective studies
|
Werner, M.
|
|
2011
|
18 |
S1 |
p. S12-S13
2 p.
|
artikel
|
| 49 |
The potential of a mistletoe (Viscum album L.) extract to alleviate adverse effects of cancer chemotherapy: An in vitro study
|
Burkhart, J.
|
|
2011
|
18 |
S1 |
p. S18-
1 p.
|
artikel
|
| 50 |
Therapeutic efficacy of natural compounds from Viscum album L. in acute lymphoblastic leukaemia
|
Delebinski, Catharina I.
|
|
2011
|
18 |
S1 |
p. S8-
1 p.
|
artikel
|
| 51 |
The role of inflammation in the pathogenesis of cancer
|
Klein, Reinhild
|
|
2011
|
18 |
S1 |
p. S4-
1 p.
|
artikel
|
| 52 |
Treatment of basal cell carcinoma with Viscum album lipophilic extract – A case series study
|
Kunz, C.
|
|
2011
|
18 |
S1 |
p. S25-
1 p.
|
artikel
|
| 53 |
Two cases of durable regression of primary B-cell cutaneous lymphoma following mistletoe treatment alone
|
Orange, M.
|
|
2011
|
18 |
S1 |
p. S10-
1 p.
|
artikel
|
| 54 |
Viscotoxin 1-PS from Scots pine mistletoe– Ecophysiological Hints
|
Seegmüller, Stefan
|
|
2011
|
18 |
S1 |
p. S22-
1 p.
|
artikel
|
| 55 |
Viscum album fermentatum Pini versus oral Etoposide as adjuvant treatment in osteosarcoma patients after second relapse
|
Longhi, A.
|
|
2011
|
18 |
S1 |
p. S14-
1 p.
|
artikel
|
| 56 |
Viscum album inhibits cell growth, migration and invasion of pediatric tumor cell lines – But effects are limited at concentrations found in serum
|
Zuzak, T.J.
|
|
2011
|
18 |
S1 |
p. S8-S9
2 p.
|
artikel
|
Tijdschrift beschrijving